We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Body Heat Drives New Drug-Delivery Micropump

By LabMedica International staff writers
Posted on 26 Sep 2012
A new study describes a miniature pump powered by fermentation and activated by body heat could be used for the manufacture of drug-delivery patches.

Researchers at Purdue University (Lafayette, IN, USA) have developed a microorganism-powered thermopneumatic pump, which contains Baker's yeast and sugar in a small chamber. More...
When water is added and the patch is placed on the skin, the body heat and the added water causes the yeast and sugar to ferment, generating a small amount of carbon dioxide (CO2) gas, which pushes against a membrane, causing the pump to work continually pump for over two hours. According to the researchers, such miniature pumps could make possible drug-delivery patches that use arrays of microneedles to deliver a wider range of medications than is now possible using conventional patches.

The pump consists of stacked layers of polydimethylsiloxane (PDMS) and a silicon substrate that form a drug reservoir, and a yeast-solution-filled working chamber. The robustness of yeast allows for long shelf life under extreme environmental conditions. The generation of CO2 is a linear function of time for a given temperature, thus allowing for a controlled volume displacement. The researchers have developed a polymeric prototype with a slow flow rate of less than 0.23 μL per minute and a maximum backpressure of 5.86 kPa. The study describing the new pump was published online on August 24, 2012, in Lab on a Chip.

“Many drugs, including those for treating cancer and autoimmune disorders, cannot be delivered with patches because they are large molecules that won't go through the skin,” said lead author Babak Ziaie, PhD, a professor of electrical and computer engineering and biomedical engineering. “Although transdermal drug delivery via microneedle arrays has long been identified as a viable and promising method for delivering large hydrophilic molecules across the skin, a suitable pump has been hard to develop.”

Related Links:

Purdue University


Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.